Use of Immune Checkpoint Inhibitors in Patients With Pre-established Inflammatory Bowel Diseases: Retrospective Case Series
Manuel B. Braga Neto, Guilherme Piovezani Ramos, Edward V. Loftus, William A. Faubion, Laura E. Raffals
Topics & Concepts
MedicineNivolumabDurvalumabIpilimumabAtezolizumabPembrolizumabInflammatory bowel diseaseImmunologyCytotoxic T cellImmune systemTremelimumabAvelumabColitisImmune checkpointImmunotherapyInternal medicineDiseaseIn vitroChemistryBiochemistryCancer Immunotherapy and BiomarkersInflammatory Bowel DiseaseImmune Cell Function and Interaction